Vital Signs with Jacob Effron and Nikhil Krishnan cover image

Ep 59: Photon Health CEO Otto Sipe on the Future of Pharmacies, PBMs and GLP-1s

Vital Signs with Jacob Effron and Nikhil Krishnan

00:00

Outcomes-Based Pricing in Pharmaceuticals

This chapter explores outcomes-based pricing models for GLP-1 drugs, emphasizing the need for better incentive structures to enhance patient adherence and dosage management. It also examines the role of AI in improving drug pricing complexities while advocating for regulatory reforms to support innovation in healthcare.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app